Breadcrumb
Last Wednesday, a group of health workers stood outside Palantir's London office beside a replica of a destroyed Palestinian ambulance. A coalition of health worker organisations, in collaboration with Amnesty International, had parked it there to send a clear message.
Palantir, the company running the NHS's patient data platform, is the same company whose CEO, Alex Karp, has publicly declared he is “the most publicly supportive CEO of Israel”. That is a state that has decimated the healthcare system across the Gaza Strip and is steadily crippling it across the West Bank.
But Palantir's ties go far beyond words. In January 2024, it signed a strategic partnership with Israel's Ministry of Defence to support its war effort. The UN special rapporteur on the occupied Palestinian territory has named Palantir as a supplier of AI tools used by the Israeli army in Gaza. The Nordic investor Storebrand dropped the company over concerns that its predictive policing systems help Israel flag Palestinians as potential "lone wolf" attackers so they can be arrested pre-emptively.
In the United States, its software helps target people for deportation.
Following the action outside Palantir's London office, activists called a national day of action. Grassroots groups across the UK organised 45 protests in more than 30 towns and cities. Nurses, porters, GPs, patients and pensioners were all asking the same question. Why is a company accused of complicity in human rights abuses, mass surveillance and genocide being trusted with our most intimate information?
Increasingly, the public is refusing to let that question go unanswered. More than 44,000 people have now filed legal objections under data protection law, asking NHS England to stop Palantir's Federated Data Platform from storing or using their records. The UK’s health innovation minister has warned that mistrust of Palantir is pushing patients to opt out of NHS data sharing altogether.
In August, NHS England was forced to apologise after admitting it had wrongly claimed that only NHS staff could access identifiable patient data. Meanwhile, the platform's projected costs have risen, its promised benefits have been revised down, and Foxglove's freedom of information requests found that nearly a third of trusts using one of its flagship tools performed fewer operations than before.
Judged purely as a product, setting its human rights record aside, Palantir's platform is costing more and delivering less.
The campaign to remove Palantir from our health system has reached a critical point, with the £330m contract due for review early next year. It is the most pressing boycott issue facing health workers today. If we fail, we will be locked in with a company accused of complicity in grave abuses, offering inferior technology, and holding our most sensitive information.
As health workers, we know that none of this is abstract, nor is it disconnected from Israel's ongoing colonisation of Palestinian land. Trust and confidentiality are the foundations of medical care. A teenager will not tell their doctor about self-harm, and a migrant mother will not bring her child to A&E, if they fear where their information ends up. When that trust breaks down, patients always pay the price.
We are often told that boycotts are empty gestures that change nothing. History says otherwise. Boycotts have a long and honourable history in healthcare. Doctors and nurses helped isolate apartheid South Africa, and the medical profession led the push to divest from tobacco until screening it out became standard practice for the BMA and the Royal Colleges. In each case, we were told it was not our place. Each time, we were proven right. Refusing to profit from harm is not politics. It is first, do no harm, applied beyond the bedside.
The past few weeks have proved the point again. After years of pressure from campaigners across the UK, long before the current genocide began, and most recently from Nurses for Palestine and the wider health worker movement, the Royal College of Nursing ended its commercial partnership with Teva UK.
Teva UK is the British arm of the Israeli drug giant, which is one of the NHS's biggest suppliers. In a letter to campaigners, the chair of the RCN's council said the college should only enter commercial relationships with companies that represent the values of the nursing profession. That sentence matters.
Our professional bodies take sponsorship money, host exhibition stands and lend their credibility to corporations every day. Choosing who they partner with is not neutral. When the world's largest nursing union, home to half a million nurses, decides a company does not reflect its values, every other royal college should take note. Medical colleges and organisations can no longer hide behind medical neutrality.
If boycotts didn't work, nobody would be trying so hard to silence the health workers calling for them. Censorship is not a side effect of this struggle. It is part of the machinery. Palantir is shielded by a contract with 417 of its 586 pages blacked out. Teva's sponsorships are presented as neutral. And those who object are treated as the problem.
So here is what health workers can do. Object to your data being processed on the Federated Data Platform, and help your patients understand that they can too. Ask your royal college, your trust and your union who sponsors them, and what those companies do. Support colleagues who are being pursued for speaking out, and do not let them stand alone.
We became health workers to protect life. That duty does not stop at the hospital door, and it does not fall silent because a regulator, a lobby group, or a tech giant would prefer it to. Outside Palantir's office last week, that ruined ambulance said what too many of our institutions will not. We intend to keep saying it until they listen.
Amira Nimerawi is a senior advocacy policy and research lead in the humanitarian sector and the co-founder and CEO of Health Workers 4 Palestine, a global grassroots movement of health professionals and allies advocating for the right to health and the end of the illegal occupation of Palestine.
Follow Amira on Instagram: @amiranimerawi @healthworkers4palestine
Dr Omar Abdel-Mannan is a British-Egyptian paediatric neurologist based in London. Since 2011, he has participated in numerous medical and teaching delegations to Gaza and the West Bank. He is the co-founder and president of Health Workers 4 Palestine.
Follow Omar on Instagram: @dr.omar.am
Have questions or comments? Email us at: editorial-english@newarab.com
Opinions expressed in this article remain those of the author and do not necessarily represent those of The New Arab, its editorial board or staff.